CH630645A5 - Process for preparing novel 17beta esters of oestradiol - Google Patents

Process for preparing novel 17beta esters of oestradiol Download PDF

Info

Publication number
CH630645A5
CH630645A5 CH616477A CH616477A CH630645A5 CH 630645 A5 CH630645 A5 CH 630645A5 CH 616477 A CH616477 A CH 616477A CH 616477 A CH616477 A CH 616477A CH 630645 A5 CH630645 A5 CH 630645A5
Authority
CH
Switzerland
Prior art keywords
carbon atoms
esters
group
estradiol
cycloaliphatic
Prior art date
Application number
CH616477A
Other languages
German (de)
English (en)
Inventor
Johannes Van Der Vies
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA762920A external-priority patent/ZA762920B/xx
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of CH630645A5 publication Critical patent/CH630645A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH616477A 1976-05-17 1977-05-17 Process for preparing novel 17beta esters of oestradiol CH630645A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA762920A ZA762920B (en) 1975-05-30 1976-05-17 Novel pharmaceutical preparation adapted for oral administration

Publications (1)

Publication Number Publication Date
CH630645A5 true CH630645A5 (en) 1982-06-30

Family

ID=25570316

Family Applications (1)

Application Number Title Priority Date Filing Date
CH616477A CH630645A5 (en) 1976-05-17 1977-05-17 Process for preparing novel 17beta esters of oestradiol

Country Status (7)

Country Link
AR (1) AR212996A1 (enrdf_load_stackoverflow)
CH (1) CH630645A5 (enrdf_load_stackoverflow)
DK (1) DK211377A (enrdf_load_stackoverflow)
ES (1) ES458836A1 (enrdf_load_stackoverflow)
FI (1) FI57762C (enrdf_load_stackoverflow)
NL (1) NL7705368A (enrdf_load_stackoverflow)
SE (1) SE425789B (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
FI771549A7 (enrdf_load_stackoverflow) 1977-11-18
SE425789B (sv) 1982-11-08
DK211377A (da) 1977-11-18
SE7705687L (sv) 1977-11-18
FI57762C (fi) 1980-10-10
ES458836A1 (es) 1978-03-16
AR212996A1 (es) 1978-11-30
NL7705368A (nl) 1977-11-21
FI57762B (fi) 1980-06-30

Similar Documents

Publication Publication Date Title
DE2661011C2 (de) 17ß-Ester von Östradiol
EP0196268B1 (de) Estriolester
US4083973A (en) Pharmaceutical preparation adapted for oral administration
DE2752695A1 (de) Steroidester
EP0188749A2 (de) Fumarsäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
CH641352A5 (de) 15-(hydroxy-, acyloxy- oder oxo-)steroide enthaltende mittel zur hemmung der biosynthese der mevalonsaeure.
DE19540233A1 (de) Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE2723876C2 (de) 17β-Ester von Testosteron
DE2818164A1 (de) 1,3-dibenzoesaeureester des 17alpha- ethinyl-7 alpha -methyl-1,3,5(10)-oestratrien- 1,3,17 beta -triols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE1801750A1 (de) Von Prostaglandinen abgeleitete Verbindungen und Verfahren zu ihrer Herstellung
DE3741801A1 (de) 17-methylen-estratriene
DE1618980B2 (de) In 17-stellung substituierte 11, 13beta-dialkylgon-4-en-3,17beta-diole und deren ester
DE3336292C2 (enrdf_load_stackoverflow)
DE3225528A1 (de) Neue derivate von ursodesoxycholsaeure
DE2720998A1 (de) Cyclische aether, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate
DD266801A5 (de) Verfahren zur herstellung einer oestrogen wirksamen verbindung
CH630645A5 (en) Process for preparing novel 17beta esters of oestradiol
US3342682A (en) Oral compositions containing 3-enol ethers of progesterone or 6-methyl derivatives thereof and method of using the same
EP0942920B1 (de) Steroidester, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE2621576A1 (de) 3,5-bisoxydierte-2-(omega-halogen- 3-oxydierte-1-alkenyl)-cyclopentan-1- oenanthsaeuren und deren derivate, die herstellung dieser verbindungen sowie diese verbindungen enthaltende praeparate
DE69328585T2 (de) Neue Alkaloidderivate, ihre Verwendung und diese enthaltende pharmazeutische Formulierungen
DE60026608T2 (de) 3-methylen steroid derivate zur behandlung von autoimmunerkrankungen
DE1643159A1 (de) Verfahren zur Herstellung von Prostaglandinderivaten und Verbindungen mit prostaglandin-aehnlicher Aktivitaet
DE1193941B (de) Verfahren zur Herstellung von therapeutisch wirksamen 16beta-Alkyl-9alpha-fluor-11beta, 17alpha, 21-trioxy-4-pregnen-3, 20-dion-21-acylaten bzw. des entsprechenden 2

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased